A panel of 12 highly potent and selective kinase inhibitors and a negative control useful for the study of Akt/PI 3-K/mTOR signaling pathway. This panel contains the following inhibitors: 1 mg of Akt Inhibitor IV (Cat. No. 124011); 1 mg of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No.124018); 5 mg of LY-294002 (Cat. No. 440202); 1 mg of LY 303511 (Cat. No. 440203); 5 mg of PDK1/Akt/Flt Dual Pathway Inhibitor (Cat. No. 521275); 1 mg of PI-103 (Cat. No. 528100); 5 mg of PI 3-Kγ Inhibitor (Cat. No. 528106); 5 mg of PI 3-Kγ Inhibitor II (Cat. No. 528108); 5 mg of PI 3-Kα Inhibitor IV (Cat. No. 528111); 5 mg of PI 3-Kα Inhibitor VIII (Cat. No. 528116); 100 µg of Rapamycin (Cat. No. 553210); 500 µg of Ro-31-8220 (Cat. No. 557520); and 1 mg of Wortmannin (Cat. No. 681675). Also provided is 15 ml of anhydrous DMSO. Supplied with a data sheet.，官网链接：https://www.sigmaaldrich.cn/product/mm/124031 默克 科研、开发、生产。 作为生命科学行业的全球领先供应商，我们致力于为科研、生物技术开发和生产，以及制药药物疗法开发和生产提供各类解决方案和服务。

非质量问题不退不换